SCHEMBL12871663

SCHEMBL12871663

CCc1c(Cl)c(C)nn1-c1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.49
HPGD P15428 3/20 0.49
HSD17B10 Q99714 2/20 0.49
POLB P06746 3/20 0.47
SMN1; SMN2 Q16637 5/20 0.46
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
MAPK1 P28482 2/20 0.44
PDE4D Q08499 1/20 0.43
NR4A3 Q92570 1/20 0.43
ALDH1A1 P00352 3/20 0.43
HTT P42858 2/20 0.43
MAPT P10636 2/20 0.43
PTGS1 P23219 1/20 0.43
PTGS2 P35354 1/20 0.43
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
LMNA P02545 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2C19 P33261 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13360872 0.82 POLB (0.49) KDM4EHPGDHSD17B10POLBSMN1; SMN2
SCHEMBL23400415 0.79 POLB (0.50) KDM4EHSD17B10POLBSMN1; SMN2MEN1
SCHEMBL12770947 0.78 MEN1 (0.65) KDM4EHPGDHSD17B10POLBSMN1; SMN2
SCHEMBL8280284 0.76 SMO (0.54) KDM4EHPGDHSD17B10SMN1; SMN2MEN1
SCHEMBL19002543 0.76 GAA (0.58) KDM4EHPGDHSD17B10POLBSMN1; SMN2
SCHEMBL15478688 0.75 HPGD (0.51) KDM4EHPGDHSD17B10POLBSMN1; SMN2
SCHEMBL11836620 0.75 SMN1; SMN2 (0.62) KDM4EHPGDHSD17B10POLBSMN1; SMN2
SCHEMBL10604503 0.74 RAB9A (0.64) KDM4EHPGDHSD17B10POLBSMN1; SMN2
SCHEMBL10798333 0.73 MAPT (0.65) KDM4EHPGDPOLBSMN1; SMN2MEN1
SCHEMBL10798336 0.73 MAPT (0.65) KDM4EHPGDPOLBSMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110046152-A1 Amide Compounds, Preparation Methods and Uses Thereof SINOCHEM CORPORATION 2011-02-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110046152-A1 Amide Compounds, Preparation Methods and Uses Thereof ACHE, MGAM, PGLS KDM4E 371/4885HPGD 2395/4885HSD17B10 4498/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.